Catalyst Wire Dossier Catalyst Wire Dossier

dexmedetomidine-ropivacaine

· Peking University First Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for dexmedetomidine-ropivacaine, covering 2024-01-03 to 2024-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Dexmedetomidine-Ropivacine Versus Sufentanil-Ropivacaine for Epidural Labor Analgesia [Phase 4]

See pricing